EUVIMEDEUVIMED entdecken
Crossref

Multitalented Hybrid Targeted Nanoconstructs Selectively Repress Survival Genes and Induce Breast Tumor Regression In Vivo

Niladri Haldar, Rajkumar Samanta, Surajit Patra, Devyani Sengar, Sachin Jadhav, Virendra Gajbhiye iD

Advanced Healthcare Materials · 2026-06 · 15 (22)

DOI: 10.1002/adhm.202505296 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 09.04.2026. Verfasst von Niladri Haldar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Nanobioscience, Agharkar Research Institute, Pune, India. Hauptthemen laut MEDLINE: Nanoparticles, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: Indian Council of Medical Research (ICMR), New Delhi, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysregulation of survival genes is a significant factor in the development of breast cancer and other cancers. Transcriptional downregulation of these genes offers a promising therapeutic strategy for cancer treatment by inducing apoptosis. Reducing expressions of these genes by RNA interference‐mediated silencing is a potential strategy for more effective gene suppression. The research developed a novel protamine biopolymer‐modified GSH‐responsive biodegradable mesoporous silica nanoparticle system to suppress MCL‐1 and Survivin genes' transcriptional activity in MCF‐7 tumor‐bearing mice. The nanocarriers were characterized using techniques like DLS, XRD, FTIR, GSH‐utilization, SEM, and TEM. The nanocarriers were tested for their ability to deliver siRNAs into target cells, and their toxic behavior was assessed in vitro and in vivo. The nanocarriers' gene silencing and anti‐cancer efficacy were assessed in both in vitro and in vivo models. The study revealed that synthesized MUC1 aptamer‐conjugated protamine‐modified nanocarriers (MPPM) offer stability to siRNAs, target MCF‐7 tumor, and induce apoptosis with dual siRNAs. Additionally, the MPPM nanocarrier demonstrated significant potential for targeting the MCF‐7 tumor in the mice model, and the histological findings suggested its biosafety profile. The siMCL‐1/siSur@MPPM nanocarriers demonstrated a significant anti‐tumor effect in an in vivo mice model through the silencing of target genes and the induction of apoptosis. These results indicate that the biodegradable siMCL‐1/siSur@MPPM nanocarrier provides a significant combination of targeted delivery, biodegradability, effective gene silencing, and reduced off‐target effects, suggesting its potential as a promising nanomedicine for breast cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesBreast NeoplasmsAnimalsFemaleHumansMCF-7 CellsRNA, Small InterferingMiceProtaminesSurvivinApoptosisSilicon DioxideMyeloid Cell Leukemia Sequence 1 ProteinInhibitor of Apoptosis ProteinsGene SilencingMice, Inbred BALB CMucin-1Aptamers, Nucleotide

Stichwörter der Autor:innen

AptamerBiodegradable MSNPsBreast cancerDual‐siRNA therapyRedox‐responsive

Substanzen

RNA, Small InterferingProtaminesSurvivinSilicon DioxideMyeloid Cell Leukemia Sequence 1 ProteinInhibitor of Apoptosis ProteinsMucin-1BIRC5 protein, humanAptamers, Nucleotide

Autor:innen und Institutionen

  • Nanobioscience, Agharkar Research Institute, Pune, India.
  • Savitribai Phule Pune University, Pune, India.

ORCID-Profile: Virendra Gajbhiye

Förderung

  • Indian Council of Medical Research (ICMR), New Delhi, India

Zitieren

APA

Haldar, N., Samanta, R., Patra, S., Sengar, D., Jadhav, S., & Gajbhiye, V. (2026). Multitalented Hybrid Targeted Nanoconstructs Selectively Repress Survival Genes and Induce Breast Tumor Regression In Vivo. Advanced Healthcare Materials, 15(22). https://doi.org/10.1002/adhm.202505296

Vancouver

Haldar N, Samanta R, Patra S, Sengar D, Jadhav S, Gajbhiye V. Multitalented Hybrid Targeted Nanoconstructs Selectively Repress Survival Genes and Induce Breast Tumor Regression In Vivo. Advanced Healthcare Materials. 2026;15(22). doi:10.1002/adhm.202505296

BibTeX
@article{Haldar2026,
  author = {Haldar, Niladri and Samanta, Rajkumar and Patra, Surajit and Sengar, Devyani and Jadhav, Sachin and Gajbhiye, Virendra},
  title = {Multitalented Hybrid Targeted Nanoconstructs Selectively Repress Survival Genes and Induce Breast Tumor Regression In Vivo},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  volume = {15},
  number = {22},
  doi = {10.1002/adhm.202505296}
}
Kostenlos starten →